Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Regardless of injection time, evidence-based management strategies include eating smaller, more frequent meals
Novo Nordisk, the manufacturer of Ozempic (semaglutide approved for diabetes) and Wegovy (semaglutide approved for obesity and other indications) has set a list price of $675 for each of these effective January 1, 2027
There have been several healthcare plans by countries and international health institutions that aim at managing diabetes and obesity
Side effects for this product are uncommon, but some people may still experience them
US$ 25.77
US$ 29.84
US$ 25.54
US$ 22.33
US$ 22.97
US$ 25.08
